NEW YORK (GenomeWeb) – PGXL Technologies said on Monday it has been awarded $149,910 to fund the development of a platform for isolating and analyzing circulating tumor cells in breast cancer.

The funding is being awarded through the Kentucky Small Business Innovation Research and Small Business Technology Transfer Matching Funds program, and will be used to match a National Institutes of Health/National Cancer Institute grant contract awarded to PGXL in the fall, the firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene regulation changes linked to human brain evolution, and more.

The New York Stem Cell Foundation's Initiative on Women in Science and Engineering working group presents seven strategies to promote gender equality in the sciences.

Researchers link a genetic variation to the ability to quickly process arsenic in people living in the Andes Mountains.

A small portion of pregnant women who've undergone non-invasive prenatal testing have found out from the test that they have cancer.